1 From the Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, California 92037.
The purpose of this study was the determination of whether hemodynamic and pharmacologic factors influence the extent and severity of myocardial necrosis produced by coronary occlusion. In 48 dogs, 10 to 14 epicardial leads were recorded on the anterior surface of the left ventricle in the distribution and vicinity of the site of occlusion of a branch of the left anterior descending coronary artery. The average S-T segment elevation for each animal was determined at 5-min intervals after occlusion. This elevation was used as an index of the presence and severity of myocardial ischemic injury. The number of sites showing this elevation provided an additional measure of the size of the injured area. Occlusion alone raised the average S-T segment elevation from 0.22 ± 0.04 to 3.32 ± 0.37 mv (SEM). Isoproterenol, ouabain, glucagon, bretylium, and tachycardia given prior to a repeated occlusion increased the severity and extent of ischemic injury, while propranolol decreased it. Elevation of arterial pressure with methoxamine reduced the occlusion-induced S-T segment elevation, and lowering of the mean arterial pressure by hemorrhage had the opposite effect. In 19 additional experiments, propranolol, isoproterenol, and alterations in arterial pressure produced similar alterations in S-T segment elevation when these interventions were applied as long as 3 hr after ligation. In a third group of dogs, myocardial creatine phosphokinase (CPK) activity was determined 24 hr after occlusion at the same sites at which epicardial electrocardiograms were taken. Depression of myocardial CPK activity in injured portions of the left ventricle 24 hr after coronary artery ligation correlated well with S-T segment elevation in the same sites 15 min after ligation. Moreover, isoproterenol increased and propranolol decreased the area of depression of myocardial CPK activity. We conclude that the hemodynamic status and neurohumoral background at the time of occlusion and for up to 3 hr thereafter can alter the extent and severity of myocardial ischemic injury and myocardial necrosis.
Submitted on July 15, 1970
© 1971 American Heart Association, Inc.
Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions
Key Words: Coronary occlusion • S-T segment elevation • Myocardial necrosis • Epicardial electrocardiogram • Myocardial oxygen consumption • Myocardial creatine phosphokinase
Accepted on September 8, 1970
This article has been cited by other articles:
 |
|
 |
|
  L. Gomez, B. Li, N. Mewton, I. Sanchez, C. Piot, M. Elbaz, and M. Ovize Inhibition of mitochondrial permeability transition pore opening: translation to patients Cardiovasc Res, July 15, 2009; 83(2): 226 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Braunwald Adventures in Cardiovascular Research Circulation, July 14, 2009; 120(2): 170 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Peart and J. P. Headrick Clinical cardioprotection and the value of conditioning responses Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1705 - H1720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. M. T. Zaman, C. J. French, D. J. Schneider, and B. E. Sobel A Profibrotic Effect of Plasminogen Activator Inhibitor Type-1 (PAI-1) in the Heart Experimental Biology and Medicine, March 1, 2009; 234(3): 246 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Heusch, A. Skyschally, P. Gres, P. van Caster, D. Schilawa, and R. Schulz Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction Eur. Heart J., September 2, 2008; 29(18): 2265 - 2275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Opie Metabolic Management of Acute Myocardial Infarction Comes to the Fore and Extends Beyond Control of Hyperglycemia Circulation, April 29, 2008; 117(17): 2172 - 2177. [Full Text] [PDF]
|
|
|
|
|
|
H. L. Lujan and S. E. DiCarlo Sex differences to myocardial ischemia and {beta}-adrenergic receptor blockade in conscious rats Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1523 - H1529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Liem, H. M. Honda, J. Zhang, D. Woo, and P. Ping Past and present course of cardioprotection against ischemia- reperfusion injury J Appl Physiol, December 1, 2007; 103(6): 2129 - 2136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ferdinandy, R. Schulz, and G. F. Baxter Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Lujan and S. E. DiCarlo T5 spinal cord transection increases susceptibility to reperfusion-induced ventricular tachycardia by enhancing sympathetic activity in conscious rats Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3333 - H3339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Lujan, V. J. Kramer, and S. E. DiCarlo Sex influences the susceptibility to reperfusion-induced sustained ventricular tachycardia and beta-adrenergic receptor blockade in conscious rats Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2799 - H2808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Vinten-Johansen, Z.-Q. Zhao, R. Jiang, A. J. Zatta, and G. P. Dobson Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury J Appl Physiol, October 1, 2007; 103(4): 1441 - 1448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J Hausenloy and D. M Yellon The evolving story of "conditioning" to protect against acute myocardial ischaemia-reperfusion injury Heart, June 1, 2007; 93(6): 649 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Lujan, V. J. Kramer, and S. E. DiCarlo Electroacupuncture decreases the susceptibility to ventricular tachycardia in conscious rats by reducing cardiac metabolic demand Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2550 - H2555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Lujan, S. L. Britton, L. G. Koch, and S. E. DiCarlo Reduced susceptibility to ventricular tachyarrhythmias in rats selectively bred for high aerobic capacity Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2933 - H2941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Heyndrickx Early reperfusion phenomena. Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2006; 10(3): 236 - 241. [Abstract] [PDF]
|
|
|
|
|
|
S. F. De Marchi, P. Meier, P. Oswald, and C. Seiler Variable ECG signs of ischemia during controlled occlusion of the left and right coronary artery in humans Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H351 - H356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Downey and M. V. Cohen We Think We See a Pattern Emerging Here Circulation, January 18, 2005; 111(2): 120 - 121. [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Gibbons, U. S. Valeti, P. A. Araoz, and A. S. Jaffe The quantification of infarct size J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1533 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bolli, L. Becker, G. Gross, R. Mentzer Jr, D. Balshaw, and D. A. Lathrop Myocardial Protection at a Crossroads: The Need for Translation Into Clinical Therapy Circ. Res., July 23, 2004; 95(2): 125 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kloner and S. H. Rezkalla Cardiac protection during acute myocardial infarction: Where do we stand in 2004? J. Am. Coll. Cardiol., July 21, 2004; 44(2): 276 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. YELLON and J. M. DOWNEY Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology Physiol Rev, October 1, 2003; 83(4): 1113 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Dauerman and B. E. Sobel Synergistic treatment of ST-segmentelevation myocardial infarction with pharmacoinvasive recanalization J. Am. Coll. Cardiol., August 20, 2003; 42(4): 646 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. W. Wang, A. Osman, J. Otero, G. A. Stouffer, S. Waxman, A. Afzal, A. Anzuini, and B. F. Uretsky Distal Myocardial Protection During Percutaneous Coronary Intervention With an Intracoronary {beta}-Blocker Circulation, June 17, 2003; 107(23): 2914 - 2919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Fraser, Z. Gao, M. J. Ozeck, and L. Belardinelli N-[3-(R)-Tetrahydrofuranyl]-6-aminopurine Riboside, an A1 Adenosine Receptor Agonist, Antagonizes Catecholamine-Induced Lipolysis without Cardiovascular Effects in Awake Rats J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 225 - 231. [Abstract] [Full Text]
|
|
|
|
|
|
J. Ross Jr From Pump to Molecules Circ. Res., March 21, 2003; 92(5): 480 - 481. [Full Text] [PDF]
|
|
|
|
|
|
E. Braunwald Personal reflections on efforts to reduce ischemic myocardial damage Cardiovasc Res, December 1, 2002; 56(3): 332 - 338. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Pfeffer and J. J.V. McMurray Myocardial Infarct: No One Size Fits All Circulation, June 4, 2002; 105(22): 2577 - 2579. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Braunwald Reperfusion therapy for acute myocardial infarction: historical context and future promise Eur. Heart J. Suppl., May 1, 2002; 4(suppl_E): E10 - E14. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Obal, B. Preckel, H. Scharbatke, J. Mullenheim, F. Hoterkes, V. Thamer, and W. Schlack One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo Br. J. Anaesth., December 1, 2001; 87(6): 905 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. de Lemos and E. Braunwald ST segment resolution as a tool for assessing the efficacy of reperfusion therapy J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1283 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.J. Hearse Ischaemia, reperfusion and cardioprotection: successes and failures in the journey from molecule to man Eur. Heart J. Suppl., June 1, 2001; 3(suppl_C): C11 - C21. [Abstract] [PDF]
|
|
|
|
 |
|
 W. W. Nichols and D. G. Edwards Arterial Elastance and Wave Reflection Augmentation of Systolic Blood Pressure: Deleterious Effects and Implications for Therapy Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2001; 6(1): 5 - 21. [Abstract] [PDF]
|
|
|
|
|
|
M. K. Al-Obaidi, P. J. Stubbs, P. Collinson, R. Conroy, I. Graham, and M. I. M. Noble Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1217 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kjekshus Distribution of myocardial injury and its relation to epicardial ST-segment change after coronary occlusion in the dog Cardiovasc Res, January 1, 2000; 45(1): 109 - 110. [Full Text] [PDF]
|
|
|
|
|
|
M. J Janse ST segment mapping and infarct size Cardiovasc Res, January 1, 2000; 45(1): 190 - 193. [Full Text] [PDF]
|
|
|
|
|
|
F. Grund, H. T. Sommerschild, T. Lyberg, K. A. Kirkeboen, and A. Ilebekk Microembolization in pigs: effects on coronary blood flow and myocardial ischemic tolerance Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H533 - H542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Grund, H. T. Sommerschild, K. A. Kirkeboen, and A. Ilebekk A new approach to normalize myocardial temperature in the open-chest pig model J Appl Physiol, June 1, 1998; 84(6): 2190 - 2197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ghaleh, Y.-T. Shen, and S. F. Vatner Spatial Heterogeneity of Myocardial Blood Flow Presages Salvage Versus Necrosis With Coronary Artery Reperfusion in Conscious Baboons Circulation, November 1, 1996; 94(9): 2210 - 2215. [Abstract] [Full Text]
|
|
|
|
|
|
K. S. Kilgore, J. L. Park, L. Chi, J. H. Musser, V. Date, S. Abbas, and B. R. Lucchesi Reduction of Myocardial Infarct Size in the Rabbit by a Carbohydrate Analog of Sialyl Lewisx Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1996; 1(1): 49 - 56. [Abstract] [PDF]
|
|
|
|
|
|
E. T. Hasche, C. Fernandes, S. B. Freedman, and R. W. Jeremy Relation Between Ischemia Time, Infarct Size, and Left Ventricular Function in Humans Circulation, August 15, 1995; 92(4): 710 - 719. [Abstract] [Full Text]
|
|
|
|
|
|
F. Niroomand, C. Weinbrenner, A. Weis, M. Bangert, C. Schwencke, R. Marquetant, T. Beyer, R. H. Strasser, W. Kubler, and B. Rauch Impaired Function of Inhibitory G Proteins During Acute Myocardial Ischemia of Canine Hearts and Its Reversal During Reperfusion and a Second Period of Ischemia : Possible Implications for the Protective Mechanism of Ischemic Preconditioning Circ. Res., May 1, 1995; 76(5): 861 - 870. [Abstract] [Full Text]
|
|
|
|
|
|
B. R. Ito Gradual Onset of Myocardial Ischemia Results in Reduced Myocardial Infarction : Association With Reduced Contractile Function and Metabolic Downregulation Circulation, April 1, 1995; 91(7): 2058 - 2070. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. A. Zikria, C. Subbarao, M. C. Oz, S. J. Popilkis, R. Sachdev, P. Chauhan, H. P. Freeman, and T. C. King Hydroxyethyl Starch Macromolecules Reduce Myocardial Reperfusion Injury Arch Surg, July 1, 1990; 125(7): 930 - 934. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Katayama, H. Yamasaki, Y. Honda, and M. Mori Clinical Significance of Initial Systolic Hypertension After Myocardial Infarction Angiology, January 1, 1990; 41(1): 23 - 29. [Abstract] [PDF]
|
|
|
|
|
|
K. Midtbo, B. Silke, S.P. Verma, G.W. Reynolds, M. Hafizullah, and S.H. Taylor Circulatory Effects of Intravenous and Oral Atenolol in Acute Myocardial Infarction Angiology, January 1, 1988; 39(9): 795 - 801. [Abstract] [PDF]
|
|
|
|
|
|
M. Fujita, D. P. McKown, M. D. McKown, and D. Franklin Opening of Coronary Collaterals by Repeated Brief Coronary Occlusions in Conscious Dogs Angiology, January 1, 1988; 39(11): 973 - 980. [Abstract] [PDF]
|
|
|
|
|
|
L. Szlavy, I. Repa, Z. Szabo, A. de Courten, and H.J. Hachen Salvage of Ischemic Myocardium by CLS 2210 in the Dog: A Preliminary Double-Blind Study Angiology, January 1, 1987; 38(1): 85 - 91. [Abstract] [PDF]
|
|
|
|
 |
|
 S. J. Phillips, R. H. Zeff, C. Kongtahworn, J. R. Skinner, L. lannone, T. M. Brown, W. Wickemeyer, and D. F. Gordon Surgery for Evolving Myocardial Infarction JAMA, September 17, 1982; 248(11): 1325 - 1328. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Moser and R. Gorlin {beta}-Blockers and Myocardial Infarction Arch Intern Med, September 1, 1982; 142(9): 1618 - 1619. [Abstract] [PDF]
|
|
|
|
|
|
ss-Blocker Heart Attack Trial Research Group A Randomized Trial of Propranolol in Patients With Acute Myocardial Infarction: I. Mortality Results JAMA, March 26, 1982; 247(12): 1707 - 1714. [Abstract] [PDF]
|
|
|
|
 |
|
 S. GOLDBERG, P. R. MAROKO, and T. R. ENGEL Intracoronary Thrombolysis for Acute Myocardial Infarction Ann Intern Med, January 1, 1982; 96(1): 115 - 117. [Abstract] [PDF]
|
|
|
|
|
|
R. E. RUDE, J. E. MULLER, and B. EUGENE Efforts to Limit the Size of Myocardial Infarcts Ann Intern Med, December 1, 1981; 95(6): 736 - 761. [Abstract] [PDF]
|
|
|
|
|
|
F. A. Cecena-Seldner and J. Villarreal Effect of the Kallikrein Inhibitor Aprotinin on Myocardial Ischemia and Necrosis in Man Angiology, July 1, 1980; 31(7): 488 - 496. [Abstract] [PDF]
|
|
|
|
|
|
R. P. Karlsberg and W. S. Aronow Reduction of Myocardial Infarct Size: Approach for the 1980s Arch Intern Med, May 1, 1980; 140(5): 616 - 619. [Abstract] [PDF]
|
|
|
|
|
|
R. Roberts Can We Clinically Measure Infarction Size? JAMA, July 13, 1979; 242(2): 183 - 185. [Abstract] [PDF]
|
|
|
|
|
|
J. E. Madias and W. B. Hood Value and Limitations of Precordial ST-Segment Mapping Arch Intern Med, April 1, 1978; 138(4): 529 - 530. [Abstract] [PDF]
|
|
|
|
|
|
D. D. WATERS and J. S. FORRESTER Myocardial Ischemia: Detection and Quantitation Ann Intern Med, February 1, 1978; 88(2): 239 - 250. [Abstract] [PDF]
|
|
|
|
 |
|
 D Maclean, M. Fishbein, P. Maroko, and E Braunwald Hyaluronidase-induced reductions in myocardial infarct size Science, October 8, 1976; 194(4261): 199 - 200. [Abstract] [PDF]
|
|
|
|
|
|
J. ROSS JR. Beta Adrenergic Blockade for Prophylaxis Against Recurrent Myocardial Infarction and Sudden Death Ann Intern Med, April 1, 1976; 84(4): 486 - 487. [Abstract] [PDF]
|
|
|
|
|
|
P. R. MAROKO, D. M. DAVIDSON, P. LIBBY, A. D. HAGAN, and E. BRAUNWALD Effects of Hyaluronidase Administration on Myocardial Ischemic Injury in Acute Infarction: A Preliminary Study in 24 Patients Ann Intern Med, April 1, 1975; 82(4): 516 - 520. [Abstract] [PDF]
|
|
|
|
|
|
S. H. RAHIMTOOLA and R. M. GUNNAR Digitalis in Acute Myocardial Infarction: Help or Hazard? Ann Intern Med, February 1, 1975; 82(2): 234 - 240. [Abstract] [PDF]
|
|
|
|
|
|
W. B. DUNKMAN, J. K. PERLOFF, J. A. KASTOR, and J. C. SHELBURNE Medical Perspectives in Coronary Artery Surgery--A Caveat Ann Intern Med, December 1, 1974; 81(6): 817 - 837. [Abstract] [PDF]
|
|
|
|
|
|
J. J. Lamberti Jr., L. H. Cohn, M. Lesch, and J. J. Collins Jr. Intra-aortic Balloon Counterpulsation: Indications and Long-Term Results in Postoperative Left Ventricular Power Failure Arch Surg, December 1, 1974; 109(6): 766 - 771. [Abstract] [PDF]
|
|
|
|
|
|
J. F. Pantridge Infarction in Patients Treated With Propranolol JAMA, November 25, 1974; 230(8): 1126 - 1126. [Abstract] [PDF]
|
|
|
|
|
|
J. N. Cohn Indications for Digitalis Therapy: A New Look JAMA, September 30, 1974; 229(14): 1911 - 1914. [Abstract] [PDF]
|
|
|
|
|
|
B. E. Sobel Serum Creatine Phosphokinase and Myocardial Infarction JAMA, July 8, 1974; 229(2): 201 - 202. [Abstract] [PDF]
|
|
|
|
|
|
D. T. MASON Digitalis Pharmacology and Therapeutics: Recent Advances Ann Intern Med, April 1, 1974; 80(4): 520 - 530. [Abstract] [PDF]
|
|
|
|
|
|
H. J. C. SWAN, K. CHATTERJEE, E. CORDAY, W. GANZ, H. MARCUS, J. MATLOFF, and W. PARMLEY Myocardial Revascularization for Acute and Chronic Coronary Heart Disease Ann Intern Med, December 1, 1973; 79(6): 851 - 866. [Abstract] [PDF]
|
|
|
|
|
|
P. R. MAROKO and E. BRAUNWALD Modification of Myocardial Infarction Size After Coronary Occlusion Ann Intern Med, November 1, 1973; 79(5): 720 - 733. [Abstract] [PDF]
|
|
|
|
|
|
M. N. Kotler, K. M. Michaelides, R. J. Bouchard, and J. R. Warbasse Myocardial Infarction Associated With Thyrotoxicosis Arch Intern Med, November 1, 1973; 132(5): 723 - 728. [Abstract] [PDF]
|
|
|
|
|
|
O. H. L. Bing, W. W. Brooks, and J. V. Messer Heart Muscle Viability following Hypoxia: Protective Effect of Acidosis Science, June 22, 1973; 180(4092): 1297 - 1298. [Abstract] [PDF]
|
|
|
|
|
|
S. E. EPSTEIN, R. E. GOLDSTEIN, D. R. REDWOOD, K. M. KENT, and E. R. SMITH The Early Phase of Acute Myocardial Infarction: Pharmacologic Aspects of Therapy Ann Intern Med, June 1, 1973; 78(6): 918 - 936. [Abstract] [PDF]
|
|
|
|
|
|
H. M. Sommers and R. B. Jennings Ventricular Fibrillation and Myocardial Necrosis After Transient Ischemia: Effect of Treatment With Oxygen, Procainamide, Reserpine, and Propranolol Arch Intern Med, May 1, 1972; 129(5): 780 - 789. [Abstract] [PDF]
|
|
|
|
|
|
J. ROTH, T. E. PROUT, I. D. GOLDFINE, S. M. WOLFE, J. MUENZER, L. E. GRAUER, and M. L. MARCUS Sulfonylureas: Effects in Vivo and in Vitro Ann Intern Med, October 1, 1971; 75(4): 607 - 621. [Abstract] [PDF]
|
|